Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Pharma
FDA warns of intestinal disorder risk with use of J&J's Carvykti
The FDA has adjusted the label of J&J's Carvykti, warning that use of the CAR-T could increase the risk a potentially fatal intestinal disorder.
Kevin Dunleavy
Oct 13, 2025 11:16am
Fierce Biotech
Novo ends all cell therapy R&D, lets go of staff
Oct 10, 2025 3:30pm
ExCellThera's blood cancer cell therapy Zemcelpro earns EU nod
Aug 27, 2025 7:40am
Fierce Biotech
Cell therapy biotech keeps adapting, selling 4 programs for $55M
Jul 28, 2025 10:52am
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Jun 20, 2025 11:55am
BioNTech to wind down cell therapy manufacturing in Maryland
Jun 18, 2025 10:23am